FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open

Mike Davis previously worked as clinical team leader at the FDA’s Division of Psychiatry before serving as chief medical officer for Usona Institute, a research organization advancing psychedelic science.